CD8A and hepatocellular carcinoma: Another study on liver cancer showed that nsPEF induced the translocation and release of PD-L1 from the hepatoma cell membrane and promoted CD8+ T-cell dysfunction, and blocking PD-L1 effectively inhibited tumor growth and improved the survival of tumor-bearing mice (115).